Breast cancer is the most frequent malignancy in women and is a heterogeneous disease on the molecular level. Over the past 10–15 years, treatment concepts have evolved to take this heterogeneity into account, with emphasis being placed on more biologically directed therapies and treatment deployed to reduce the adverse effects of treatment. Despite the inherent molecular heterogeneity which is a driving principle of modern day treatments, some features such as the impact of locoregional tumour burden or metastatic patterns are shared and influence therapy.
A lady posted her picture online after she survived a breast cancer survey.
Early breast cancer that is, cancer that is contained in the breast or that has only spread to the axillary lymph nodes is considered curable. Improvements in multimodal therapy have led to increasing chances for cure in 70 to 80% of patients. By contrast, advanced (metastatic) disease is not considered curable using currently available therapeutic options. However, advanced breast cancer is a treatable disease, for which the main goals of therapy are to prolong survival and control symptoms with low treatment associated toxicity to maintain or improve quality of life.
Content created and supplied by: Osheanews (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More